Metagenomi Therapeutics (MGX) Other Working Capital Changes (2023 - 2026)
Metagenomi Therapeutics (MGX) posted quarterly Other Working Capital Changes of $33000.0 for Q4 2025, up 102.36% year-over-year from $16307.4 in Q4 2024, and up 114.1% quarter-over-quarter from -$234000.0 in Q3 2025.
Metagenomi Therapeutics (MGX) Other Working Capital Changes (2023 - 2026) Analysis & Trends
Metagenomi Therapeutics (MGX) has reported Other Working Capital Changes for 3 consecutive years, with $33000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Other Working Capital Changes rose 102.36% year-over-year to $33000.0; the TTM figure through Mar 2026 stood at -$156000.0 (up 95.01% YoY), while the FY2025 annual figure was -$58000.0, up 98.29% from the prior year.
- Other Working Capital Changes rose to $33000.0 in Q4 2025 per MGX's latest filing, from -$234000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $1.5 million in Q4 2023 and bottomed at -$3.0 million in Q1 2025.
- Historically, Other Working Capital Changes has averaged -$86923.1 across 4 years, with a median of -$118000.0 in 2023.
- Annual changes were most pronounced in 2024 — Other Working Capital Changes slumped 552.8% — and 2025, when it soared 154.75%.
- Metagenomi Therapeutics' Other Working Capital Changes stood at -$214000.0 in 2023, then plunged by 552.8% to -$1.4 million in 2024, then jumped by 102.36% to $33000.0 in 2025.
- Business Quant data shows MGX's Other Working Capital Changes at $33000.0 in Q4 2025, -$234000.0 in Q3 2025, and $45000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Metagenomi Therapeutics | 46.51 Mn | 46.51 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.47 Mn |
| Jun 30, 2026 | -1.47 Mn |
| Jun 30, 2026 | -1.47 Mn |
| Mar 31, 2026 | -1.47 Mn |
| Mar 31, 2026 | -1.47 Mn |
| Mar 31, 2026 | -1.47 Mn |
| Dec 31, 2025 | 33,000.00 |
| Dec 31, 2025 | 33,000.00 |
| Dec 31, 2025 | 33,000.00 |
| Sep 30, 2025 | -234,000.00 |
| Sep 30, 2025 | -234,000.00 |
| Sep 30, 2025 | -234,000.00 |
| Jun 30, 2025 | 45,000.00 |
| Jun 30, 2025 | 45,000.00 |
| Jun 30, 2025 | 45,000.00 |
| Mar 31, 2025 | 98,000.00 |
| Mar 31, 2025 | 98,000.00 |
| Mar 31, 2025 | 98,000.00 |
| Dec 31, 2024 | -1.40 Mn |
| Dec 31, 2024 | -1.40 Mn |